Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

466 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

NCT04567602

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Generale Regionale F. Miulli Acquaviva delle Fonti, Italy
  • A.O. Universitaria Ospedali Riuniti di Ancona Ancona, Italy
  • Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari, Italy
  • Ospedale Di Venere Bari, Italy
View all 30 locations
View Trial Details
Completed

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

NCT02036970

Conditions
Acute Interstitial Pneumonitis, Bronchial Diseases, Bronchiolitis, +32 more
Locations
  • Banner University Medical Center, Phoenix Advanced Lung Disease Institute Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • VA Healthcare System of Greater Los Angeles Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

NCT04712669

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • University of California San Diego Health Sciences La Jolla, California, United States
  • VA Greater LA Healthcare System/UCLA Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

NCT04732221

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • University of California San Diego Health-Pulmonary Critical Care ( Site 0061) La Jolla, California, United States
  • University of California Davis Health-Internal Medicine: Pulmonary, Critical Care and Sleep Medicine Sacramento, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights ( Site 0063) San Francisco, California, United States
  • University of Colorado - Denver ( Site 0003) Aurora, Colorado, United States
View all 91 locations
View Trial Details
Completed

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

NCT03754660

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Vseobecna fakultni nemocnice v Praze Prague, Czechia
  • Institut Klinicke a Experimentalni Mediciny Prague, Czechia
  • Krankenhaus Neuwittelsbach München, Bavaria, Germany
View Trial Details
Completed

A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.

NCT03422328

Conditions
Chronic Thromboembolic Pulmonary Hypertension, Hypertension, Pulmonary, Lung Diseases, +2 more
Locations
  • The Republican Scientific-Practical Center ''Cardiology'' Minsk, Belarus
  • UZ Leuven Leuven, Belgium
  • CHRU Besancon Hopital Jean Minjoz Besançon, France
  • CHU de Bordeaux - Hospital Haut-Leveque Bordeaux (Pessac), France
View all 34 locations
View Trial Details
Completed

(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)

NCT03362047

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations
  • Klinik III für Innere Medizin Herzzentrum der Universität zu Köln Cologne, Germany
  • Abteilung Pneumologie und Intensivmedizin der Medizinischen Klinik II, Uniklinik Gießen und Marburg Standort Gießen Giessen, Germany
  • Krankenhaus Neuwittelsbach, Innere Medizin II München, Germany
View Trial Details
Completed

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

NCT00667823

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • GLVA Healthcare Center Los Angeles, California, United States
View all 158 locations
View Trial Details

Related conditions